Salta al contenuto principale
Passa alla visualizzazione normale.

MANFREDI RIZZO

Pubblicazioni

Data Titolo Tipologia Scheda
2023 Has the time come to step up to "triple therapy" for the treatment of diabetic kidney disease? Nota o commento Vai
2023 A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study Articolo in rivista Vai
2023 Is subclinical cardiovascular disease linked with periodontal disease in diabetic and non-diabetic subjects? Articolo in rivista Vai
2023 Lipoprotein subclasses and early kidney dysfunction in young type 1 diabetes mellitus patients Nota o commento Vai
2023 GLP-1 receptor agonists and SGLT2 inhibitors: The need to shed light on their safety risks real dimension and possible mechanisms Articolo in rivista Vai
2023 New-Onset Diabetes Mellitus in COVID-19: A Scoping Review Review essay (rassegna critica) Vai
2023 Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review Nota o commento Vai
2023 Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature Articolo in rivista Vai
2023 Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update Review essay (rassegna critica) Vai
2023 Novel Anti-obesity Therapies and their Different Effects and Safety Profiles: A Critical Overview Articolo in rivista Vai
2023 Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials Articolo in rivista Vai
2023 Semaglutide in Obesity: Unmet Needs in Men Nota o commento Vai
2023 A Critical View over the Newest Antidiabetic Molecules in Light of Efficacy-A Systematic Review and Meta-Analysis Review essay (rassegna critica) Vai
2023 The Role of Advanced Glycation End Products on Dyslipidemia Review essay (rassegna critica) Vai
2023 The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance Articolo in rivista Vai
2023 Timing Is Important-Management of Metabolic Syndrome According to the Circadian Rhythm Review essay (rassegna critica) Vai
2023 Capacity of HDL to Efflux Cellular Cholesterol from Lipid-Loaded Macrophages Is Reduced in Patients with Familial Hypercholesterolemia Articolo in rivista Vai
2023 Does Iodine Influence the Metabolism of Glucose? Articolo in rivista Vai
2023 Novel Selective PPARα Modulator Pemafibrate for Dyslipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), and Atherosclerosis Review essay (rassegna critica) Vai
2023 Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials Articolo in rivista Vai
2023 Antidiabetic Molecule Efficacy in Patients with Type 2 Diabetes Mellitus-A Real-Life Clinical Practice Study Articolo in rivista Vai
2023 Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes Articolo in rivista Vai
2023 Efficient Generation of Chondrocytes From Bone Marrow-Derived Mesenchymal Stem Cells in a 3D Culture System: Protocol for a Practical Model for Assessing Anti-Inflammatory Therapies Articolo in rivista Vai
2023 Epicardial, peripancreatic and other "orthotopic" excessive fat deposition in south Asians and Europeans: Are differences clinically relevant? Articolo in rivista Vai
2023 GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now? Articolo in rivista Vai
2023 Oxidative Stress, Atherogenic Dyslipidemia, and Cardiovascular Risk Review essay (rassegna critica) Vai
2023 Potassium Iodide in Nuclear Accidents: Give it Timely, Swiftly and Judiciously Articolo in rivista Vai
2023 PUFA treatment in patients with gestational diabetes mellitus: Lights and shadows Articolo in rivista Vai
2023 Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP) Articolo in rivista Vai
2023 ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON) Articolo in rivista Vai
2023 Tirzepatide and glucagon-like peptide-1 receptor agonists: safety always comes first! Nota o commento Vai
2023 Editorial: Diet-microbe-host interactions in metabolic syndrome Nota o commento Vai
2023 The Na+/K+-ATPase: A potential therapeutic target in cardiometabolic diseases Articolo in rivista Vai
2023 Effect of Glucagon-like Peptide-1 Receptor Agonists on Cardio-Metabolic Risk Factors among Obese/Overweight Individuals Treated with Antipsychotic Drug Classes: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials Review essay (rassegna critica) Vai
2023 Efficacy and safety of once-weekly versus once-daily basal insulin analogues in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis Articolo in rivista Vai
2023 Absolute Hyperglycemia versus Stress Hyperglycemia Ratio for the Prognosis of Hospitalized Patients with COVID-19 in the First Months of the Pandemic: A Retrospective Study Articolo in rivista Vai
2023 Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm? Review essay (rassegna critica) Vai
2023 Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and uric acid: More good news! Articolo in rivista Vai
2023 The effect of Spirulina supplementation on lipid profile: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials Articolo in rivista Vai
2023 Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement Articolo in rivista Vai
2023 The Effect of Curcumin on the Gut-Brain Axis: Therapeutic Implications Review essay (rassegna critica) Vai
2023 The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study Articolo in rivista Vai
2023 The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials Articolo in rivista Vai
2023 The legacy effect in early-stage diabetes: Don't stay by me, cardiovascular disease! Articolo in rivista Vai
2023 Infection with Helicobacter pylori may predispose to atherosclerosis: role of inflammation and thickening of intima-media of carotid arteries Articolo in rivista Vai
2022 Associations between Periodontitis, COVID-19, and Cardiometabolic Complications: Molecular Mechanisms and Clinical Evidence Articolo in rivista Vai
2022 The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact Articolo in rivista Vai
2022 Alteration in Redox Status and Lipoprotein Profile in COVID-19 Patients with Mild, Moderate, and Severe Pneumonia Articolo in rivista Vai
2022 An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes Articolo in rivista Vai
2022 Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL Review essay (rassegna critica) Vai
2022 Biosimilar and generic formulations of novel antidiabetic drugs: the role of liraglutide in clinical pharmacology of type 2 diabetes Nota o commento Vai
2022 Managing the Systemic Impact of Periodontitis Review essay (rassegna critica) Vai
2022 Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS) Articolo in rivista Vai
2022 Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence Review essay (rassegna critica) Vai
2022 Current and emerging drugs for the treatment of atherosclerosis: the evidence to date Review essay (rassegna critica) Vai
2022 Familial Hypercholesterolemia and Lipoprotein(a): A Gordian Knot in Cardiovascular Prevention Review essay (rassegna critica) Vai
2022 Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review Review essay (rassegna critica) Vai
2022 Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly Articolo in rivista Vai
2022 Effect of Bariatric Surgery on Intima Media Thickness: A Systematic Review and Meta-Analysis Review essay (rassegna critica) Vai
2022 A New Comorbidity in Periodontitis: Fusobacterium nucleatum and Colorectal Cancer Review essay (rassegna critica) Vai
2022 Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysis Articolo in rivista Vai
2022 Glucose Metabolism Disorders: Challenges and Opportunities for Diagnosis and Treatment Nota o commento Vai
2022 Effects of Gestational Diabetes Mellitus on Cholesterol Metabolism in Women with High-Risk Pregnancies: Possible Implications for Neonatal Outcome Articolo in rivista Vai
2022 Critical questions in diabetes management: What are the most compelling challenges and how can we handle them? Articolo in rivista Vai
2022 Diabetes and COVID-19: What 2 Years of the Pandemic Has Taught Us Articolo in rivista Vai
2022 Post-COVID syndrome, inflammation, and diabetes Articolo in rivista Vai
2022 Reconnoitering the Therapeutic Role of Curcumin in Disease Prevention and Treatment: Lessons Learnt and Future Directions Review essay (rassegna critica) Vai
2022 Oxidative Stress and Inflammatory Biomarkers in Patients with Diabetic Foot Articolo in rivista Vai
2022 Personalized management of dyslipidemias in patients with diabetes-it is time for a new approach (2022) Review essay (rassegna critica) Vai
2022 Metformin: Sex/Gender Differences in Its Uses and Effects-Narrative Review Review essay (rassegna critica) Vai
2022 Novel Pharmaceutical and Nutraceutical-Based Approaches for Cardiovascular Diseases Prevention Targeting Atherogenic Small Dense LDL Review essay (rassegna critica) Vai
2022 Obesity and HFpEF Nota o commento Vai
2022 Obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients Nota o commento Vai
2022 Role of Chemerin in Cardiovascular Diseases Review essay (rassegna critica) Vai
2022 Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections Nota o commento Vai
2022 Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP) Articolo in rivista Vai
2022 The Effects of Statin Treatment on Serum Ferritin Levels: A Systematic Review and Meta-Analysis Articolo in rivista Vai
2022 Statins and angiogenesis in non-cardiovascular diseases Review essay (rassegna critica) Vai
2022 The Role of Physicians' Digital Tools in Pharmacological Management of Type 2 Diabetes Mellitus Articolo in rivista Vai
2022 The Therapeutic Role of SGLT-2 Inhibitors in Acute Heart Failure: From Pathophysiologic Mechanisms to Clinical Evidence with Pooled Analysis of Relevant Studies across Safety and Efficacy Endpoints of Interest Review essay (rassegna critica) Vai
2022 Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert group Articolo in rivista Vai
2022 Treatment of diabetes and heart failure: Facts and hopes Nota o commento Vai
2022 The regulation of efferocytosis signaling pathways and adipose tissue homeostasis in physiological conditions and obesity: Current understanding and treatment options Review essay (rassegna critica) Vai
2022 Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study Articolo in rivista Vai
2022 Vitamin D in the Prevention and Treatment of Diabetic Neuropathy Review essay (rassegna critica) Vai
2022 The Relationship between COVID-19 and Hypothalamic-Pituitary-Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess-The CAPISCO International Expert Panel Review essay (rassegna critica) Vai
2022 Weight response to GLP-1 receptor agonists: Why women do it better? Nota o commento Vai
2022 The Effect of Bariatric Surgery on Circulating Levels of Lipoprotein (a): A Meta-analysis Review essay (rassegna critica) Vai
2022 The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction Articolo in rivista Vai
2022 Correlations between Diabetes Mellitus Self-Care Activities and Glycaemic Control in the Adult Population: A Cross-Sectional Study Articolo in rivista Vai
2022 A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies Review essay (rassegna critica) Vai
2022 Glycemic Variability, Glycated Hemoglobin, and Cardiovascular Complications: Still a Dilemma in Clinical Practice Nota o commento Vai
2022 Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia Articolo in rivista Vai
2022 The Role of the Metabolome and Non-Coding RNA on Pheochromocytomas and Paragangliomas: An Update Articolo in rivista Vai
2022 Glucose transporter 4 mRNA expression in subcutaneous adipose tissue of women with PCOS remains unchanged despite metformin withdrawal: is there a cellular metabolic treatment legacy effect? Articolo in rivista Vai
2022 Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes Review essay (rassegna critica) Vai
2022 The Role of Fructose as a Cardiovascular Risk Factor: An Update Articolo in rivista Vai
2022 Neurological Consequences, Mental Health, Physical Care, and Appropriate Nutrition in Long-COVID-19 Review essay (rassegna critica) Vai
2022 Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health Articolo in rivista Vai
2022 Advanced Glycation End Products: Do They Impair Bone Health in Diabetes? Nota o commento Vai
2021 Preliminary results of citraves™ effects on low density lipoprotein cholesterol and waist circumference in healthy subjects after 12 weeks: A pilot open-label study Articolo in rivista Vai
2021 Postmarketing nutrivigilance safety profile: A line of dietary food supplements containing red yeast rice for dyslipidemia Articolo in rivista Vai
2021 Novel therapeutical approaches to managing atherosclerotic risk Review essay (rassegna critica) Vai
2021 Genetic and Epigenetic Biomarkers For Diagnosis, Prognosis and Treatment Of Metabolic Syndrome Review essay (rassegna critica) Vai
2021 LE VESCICOLE EXTRACELLULARI VEGETALI PER LO SVILUPPO DI NUOVI NUTRACEUTICI: STUDIO PRE-CLINICO E CLINICO DELLE PROPRIETÀ BIOLOGICHE DELLE VESCICOLE ISOLATE DA SUCCO DI LIMONE Abstract in atti di convegno pubblicato in rivista Vai
2021 Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel Articolo in rivista Vai
2021 Long-term brain disorders in post covid-19 neurological syndrome (Pcns) patient Articolo in rivista Vai
2021 Lipoproteins and cardiovascular disease: An update on the clinical significance of atherogenic small, dense LDL and new therapeutical options Articolo in rivista Vai
2021 Exploring the role of skeletal muscle in insulin resistance: lessons from cultured cells to animal models Review essay (rassegna critica) Vai
2021 Reconnoitering the role of long-noncoding rnas in hypertrophic cardiomyopathy: A descriptive review Review essay (rassegna critica) Vai
2021 The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism Articolo in rivista Vai
2021 Filling the gap between Guidelines and Real World in the cardiovascular approach to the diabetic patients: the need for a call to action Nota o commento Vai
2021 Incretin-based therapies in 2021 – Current status and perspectives for the future Nota o commento Vai
2021 Glucagon-like peptide 1 and taste perception: From molecular mechanisms to potential clinical implications Articolo in rivista Vai
2021 Significance of Neutrophil to Lymphocyte Ratio (NLR) and Platelet Lymphocyte Ratio (PLR) in Diabetic Foot Ulcer and Potential New Therapeutic Targets Review essay (rassegna critica) Vai
2021 Diabetes and colorectal cancer risk: A new look at molecular mechanisms and potential role of novel antidiabetic agents Review essay (rassegna critica) Vai
2021 Betatrophin levels are related to the early histological findings in nonalcoholic fatty liver disease Articolo in rivista Vai
2021 Statin intolerance: new data and further options for treatment Review essay (rassegna critica) Vai
2021 New Sub-Phenotyping of Subjects at High Risk of Type 2 Diabetes: What Are the Potential Clinical Implications? Nota o commento Vai
2021 Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review Review essay (rassegna critica) Vai
2021 Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP) Articolo in rivista Vai
2021 Diabetes and COVID-19: A Tale of 2 Pandemics Nota o commento Vai
2021 Semaglutide reduces fat accumulation in the tongue: A randomized single-blind, pilot study Articolo in rivista Vai
2021 The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP) Articolo in rivista Vai
2021 Adoption of the ADA/EASD guidelines in 10 Eastern and Southern European countries: Physician survey and good clinical practice recommendations from an international expert panel Articolo in rivista Vai
2021 The evolving role of fetuin‐a in nonalcoholic fatty liver disease: An overview from liver to the heart Review essay (rassegna critica) Vai
2021 Challenges and opportunities on lipid metabolism disorders diagnosis and therapy: Novel insights and future perspective Nota o commento Vai
2021 Metabolic syndrome: From molecular mechanisms to novel therapies Nota o commento Vai
2021 Molecular endocrinology and metabolism in 2021: What’s new Nota o commento Vai
2021 Post-acute COVID-19 neurological syndrome: A new medical challenge Articolo in rivista Vai
2021 The role of endothelium in covid-19 Review essay (rassegna critica) Vai
2021 Cardiometabolic alterations in the interplay of covid-19 and diabetes: Current knowledge and future avenues Nota o commento Vai
2021 Crispr gene editing in lipid disorders and atherosclerosis: Mechanisms and opportunities Review essay (rassegna critica) Vai
2021 Endocrinology in the time of covid-19: A rapid evolution of knowledge and care Nota o commento Vai
2021 Gender differences in the battle against COVID-19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes Articolo in rivista Vai
2021 Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story Nota o commento Vai
2021 Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect Articolo in rivista Vai
2021 Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus Review essay (rassegna critica) Vai
2020 Comparison of Reported Deaths From COVID-19 and Increase in Total Mortality in Italy Lettera Vai
2020 COVID-19 and diabetes management: What should be considered? Nota o commento Vai
2020 Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect Articolo in rivista Vai
2020 Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study Articolo in rivista Vai
2020 An overview of statin-induced myopathy and perspectives for the future Articolo in rivista Vai
2020 Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study Articolo in rivista Vai
2020 Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors Articolo in rivista Vai
2020 Drug Induced Liver Injury (DILI) due to variability in monacolin K content in Red Yeast Rice (RYR): An expert opinion Articolo in rivista Vai
2020 Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study Articolo in rivista Vai
2020 Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management Nota o commento Vai
2020 Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights Articolo in rivista Vai
2020 Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis Articolo in rivista Vai
2020 Current pharmacological treatment of painful diabetic neuropathy: A narrative review Review essay (rassegna critica) Vai
2020 Diabetes and renin-angiotensin-aldosterone system: Implications for covid-19 patients with diabetes treatment management Review essay (rassegna critica) Vai
2020 Safety Evaluation of α-Lipoic Acid Supplementation: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical Studies Articolo in rivista Vai
2020 Nlrp3 inflammasome biomarker—could be the new tool for improved cardiometabolic syndrome outcome Review essay (rassegna critica) Vai
2020 Gut microbiota and aging-A focus on centenarians Articolo in rivista Vai
2020 Efficacy of a fasting‐mimicking diet in functional therapy for depression: A randomised controlled pilot trial Articolo in rivista Vai
2019 A NOVEL THERAPEUTIC APPROACH TO COLORECTAL CANCER IN DIABETES: ROLE OF METFORMIN AND RAPAMYCIN Articolo in rivista Vai
2019 Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study Articolo in rivista Vai
2019 Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study Articolo in rivista Vai
2019 Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study Articolo in rivista Vai
2019 Gut microbiota, obesity and bariatric surgery: Current knowledge and future perspectives Articolo in rivista Vai
2019 Effects of aging and diet on cardioprotection and cardiometabolic risk markers Articolo in rivista Vai
2019 Advances in pharmacological treatment of type 1 diabetes during pregnancy Review essay (rassegna critica) Vai
2019 Future perspectives of the pharmacological management of diabetic dyslipidemia Review essay (rassegna critica) Vai
2019 Psoriasis and acute coronary syndrome risk Nota o commento Vai
2019 Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children Nota o commento Vai
2018 Statins in liver disease: not only prevention of cardiovascular events Articolo in rivista Vai
2018 GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms Articolo in rivista Vai
2018 Natural approaches in metabolic syndrome management Review essay (rassegna critica) Vai
2018 Serum lipoproteins are not associated with the severity of asthma Articolo in rivista Vai
2018 Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study Articolo in rivista Vai
2018 Management of Statin Intolerance in 2018: Still More Questions Than Answers Articolo in rivista Vai
2018 Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas? Articolo in rivista Vai
2018 Pharmacotherapy for gestational diabetes Articolo in rivista Vai
2018 Polyphenols: Potential use in the prevention and treatment of cardiovascular diseases Articolo in rivista Vai
2018 The Role of Nutraceuticals in Statin Intolerant Patients Articolo in rivista Vai
2018 Metabolic disorders during pregnancy and postpartum cardiometabolic risk Articolo in rivista Vai
2017 Oral manifestations of inflammatory bowel disease Articolo in rivista Vai
2017 NUTRACEUTICALS IMPROVE EXPERIMENTAL COLITIS: PLACE OF CATECHINS IN THE 2,4,6-TRINITROBENZENE SULFONIC ACID MODEL RATS Contributo in atti di convegno pubblicato in volume Vai
2017 NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet Articolo in rivista Vai
2017 Tea catechins induce crosstalk between signaling pathways and stabilize mast cells in ulcerative colitis Articolo in rivista Vai
2017 Nutraceuticals as an important part of combination therapy in dyslipidaemia Review essay (rassegna critica) Vai
2017 Intensive LDL-cholesterol lowering therapy and neurocognitive function Articolo in rivista Vai
2017 Lifestyle recommendations for the prevention and management of metabolic syndrome: An international panel recommendation Articolo in rivista Vai
2017 Small, dense LDL: An update Articolo in rivista Vai
2017 GLP-1 receptor agonists, carotid atherosclerosis and retinopathy Nota o commento Vai
2017 PPAR agonists, atherogenic dyslipidemia and cardiovascular risk Review essay (rassegna critica) Vai
2016 In vivo triglyceride synthesis in subcutaneous adipose tissue of humans correlates with plasma HDL parameters Articolo in rivista Vai
2016 Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study Articolo in rivista Vai
2016 IMPROVE-IT: What have we learned? Articolo in rivista Vai
2016 Anti-cytokine therapy for prevention of atherosclerosis Articolo in rivista Vai
2016 Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study Articolo in rivista Vai
2016 The effect of bergamot on dyslipidemia Articolo in rivista Vai
2016 Incretins, pregnancy, and gestational diabetes Articolo in rivista Vai
2016 Gli effetti extraglicemici di liraglutide: Focus sui marker cardiometabolici Articolo in rivista Vai
2016 Circulating miR-130a, miR-27b, and miR-210 in Patients with Peripheral Artery Disease and Their Potential Relationship with Oxidative Stress: A Pilot Study Articolo in rivista Vai
2016 Nutraceuticals as lipid-lowering treatment in pregnancy and their effects on the metabolic syndrome Articolo in rivista Vai
2015 Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 And Ghrelin Levels In Patients With Type 2 Diabetes: a prospective pilot study. Articolo in rivista Vai
2015 Oxidative stress markers at birth: Analyses of a neonatal population Articolo in rivista Vai
2015 Nutraceuticals in Lipid-Lowering Treatment: A Narrative Review on the Role of Chitosan Articolo in rivista Vai
2015 Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study Articolo in rivista Vai
2015 Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease Articolo in rivista Vai
2015 Lipid subclasses profiles and oxidative stress in aggressive periodontitis before and after treatment Articolo in rivista Vai
2015 An evaluation of RVX-208 for the treatment of atherosclerosis Articolo in rivista Vai
2015 Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome Articolo in rivista Vai
2015 Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel Articolo in rivista Vai
2015 A Potential Link between Serum Low-Density Lipoproteins and Asthma Articolo in rivista Vai
2015 Statin intolerance - An attempt at a unified definition. Position paper from an International Lipid Expert Panel Articolo in rivista Vai
2014 Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study eedings Vai
2014 The effects of anti-diabetic drugs on LDL subclasses: any role for colesevelam? Articolo in rivista Vai
2014 Association between COX-2 rs 6681231 genotype and interleukin-6 in periodontal connective tissue. A pilot study. Articolo in rivista Vai
2014 Treatment options for managing atherogenic dyslipidemia and fatty liver disease Abstract in rivista Vai
2014 Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. Articolo in rivista Vai
2014 Exploring lipid-related treatment options for the treatment of NASH. Articolo in rivista Vai
2014 Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. Articolo in rivista Vai
2014 The Metabolic Syndrome and HIV Infection. Articolo in rivista Vai
2014 Periodontitis, blood lipids and lipoproteins. Articolo in rivista Vai
2014 New Obesity Indices and Adipokines in Normotensive Patients and Patients With Hypertension: Comparative Pilot Analysis. Articolo in rivista Vai
2014 Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis Articolo in rivista Vai
2014 Effects of Liraglutide on Metabolic Parameters and Carotid Intima-Media Thickness in Patients with The Metabolic Syndrome: A 12-Month Prospective Pilot Study Altro Vai
2014 Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study Altro Vai
2014 Effects of lipid-lowering drugs on high-density lipoprotein subclasses in healthy men-a randomized trial Articolo in rivista Vai
2014 High plasma levels of endothelin-1 enhance the predictive value of preclinical atherosclerosis for future cerebrovascular and cardiovascular events: a 20-year prospective study Articolo in rivista Vai
2014 SUBFRACTIONS AND SUBPOPULATIONS OF HDL: AN UPDATE Articolo in rivista Vai
2014 Managing the Cardiovascular Risk Associated with the Metabolic Syndrome Articolo in rivista Vai
2014 Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study Articolo in rivista Vai
2014 Gestational Diabetes and the Metabolic Syndrome: Can Obesity and Small, Dense Low Density Lipoproteins Be Key Mediators Of This Association? Articolo in rivista Vai
2014 Predictors of insulin resistance in patients with obesity: a pilot study. Articolo in rivista Vai
2014 ETC-1002: A future option for lipid disorders? Articolo in rivista Vai
2014 Resistin: An inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome Articolo in rivista Vai
2014 Prevalence of dyslipidemia and associated risk factors in Turkish adults. Articolo in rivista Vai
2013 Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches. Articolo in rivista Vai
2013 The role of fibrate treatment in dyslipidemia: an overview. Articolo in rivista Vai
2013 Effect of hypolipidemic treatment on emerging risk factors in mixed dyslipidaemia: a randomized pilot tria Articolo in rivista Vai
2013 Rational for statin use in psoriatic patients Articolo in rivista Vai
2013 Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy-A meta-analysis of 11 randomized controlled trials involving 21,295 participants Articolo in rivista Vai
2013 Mipomersen: A lipid-lowering agent with a novel mechanism of action Articolo in rivista Vai
2013 Atorvastatin in stable angina patients lowers CCL2 and ICAM1 expression: Pleiotropic evidence from plasma mRNA analyses. Articolo in rivista Vai
2013 Anti-atherogenic Effects of 17β-Estradiol Articolo in rivista Vai
2013 Uric acid metabolism in pre-hypertension and the metabolic syndrome Articolo in rivista Vai
2013 A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? Articolo in rivista Vai
2013 STATINS AND NEW-ONSET DIABETES Articolo in rivista Vai
2013 Clinical anatomic, immunomorphologic and molecular anatomic data suggest interplay of thyroidal molecules, autoantibodies and Hsp60 in Hashimoto’s disease eedings Vai
2013 Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia? Articolo in rivista Vai
2013 INCRETIN-BASED THERAPIES, GLUCOMETABOLIC HEALTH AND ENDOVASCULAR INFLAMMATION Articolo in rivista Vai
2013 Serological, immunomorphological and bioinformatics analyses suggest Hsp60 is involved in Hashimoto’s thyroiditis pathogenesis. eedings Vai
2013 Beyond cholesterol reduction, the pleiotropic effects of statins: is their use in cancer prevention hype or hope? Articolo in rivista Vai
2013 Association between metabolic syndrome and periodontitis: a systematic review and meta-analysis Articolo in rivista Vai
2013 Postprandial metabolism: from research to clinical practice. Articolo in rivista Vai
2013 Statin treatment in the elderly: how much do we know? Articolo in rivista Vai
2013 Smoking and small, dense low-density lipoproteins. Recensione in rivista Vai
2013 Serum low density lipoprotein subclasses in asthma Articolo in rivista Vai
2013 Should low high-density lipoprotein cholesterol (HDL-C) be treated? Articolo in rivista Vai
2013 Emerging Therapies For Raising Hdl-C And Augmenting Hdl Particle Functionality Articolo in rivista Vai
2013 Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases Articolo in rivista Vai
2013 The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspectives. Articolo in rivista Vai
2013 Emerging approaches for the treatment of hypertriglyceridemia. Articolo in rivista Vai
2013 Non-glycemic effects of pioglitazone and incretin-based therapies. Articolo in rivista Vai
2013 The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy -- 5-year follow-up. Articolo in rivista Vai
2013 Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials. Articolo in rivista Vai
2012 Oxidative stress and small, dense low-density lipoproteins: Current and future perspectives Articolo in rivista Vai
2012 Lipoprotein alterations and reduced growth hormone secretion: relationships with obesity and cardiovascular risk Articolo in rivista Vai
2012 Prevalence of metabolic syndrome: a comparative analysis in an unselected sample of mediterranean subjects. Articolo in rivista Vai
2012 Clinical benefits of ezetimibe use: is absence of proof, proof of absence? Articolo in rivista Vai
2012 The effects of statins on blood pressure: current knowledge and future perspectives. Articolo in rivista Vai
2012 Effect of liraglutide on carotid intima-media thickness in patients with type-2 diabetes: a 4-month prospective study Abstract in rivista Vai
2012 Medical therapy for patients with subclinical and clinical carotid atherosclerosis Articolo in rivista Vai
2012 Size and subclasses of low-density lipoproteins in patients with obstructive sleep apnea. Articolo in rivista Vai
2012 Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. Articolo in rivista Vai
2012 A novel beneficial effect of liraglutide: the reduction in subclinical atherosclerosis in patients with type-2 diabetes. Abstract in rivista Vai
2012 The role of elevated growth hormone on the increased atherosclerosis in patients with acromegaly. Articolo in rivista Vai
2012 Heat-shock protein 60 kDa and atherogenic dyslipidemia in patients with untreated mild periodontitis: a pilot study. Articolo in rivista Vai
2012 Effects of liraglutide on plasma ghrelin concentrations and oxidative stress in patients with type 2 diabetes: a 2-month prospective pilot study. Abstract in rivista Vai
2012 Lipid-lowering therapies and achievement of LDL-cholesterol targets. Articolo in rivista Vai
2012 The role of macrophage colony-stimulating factor in patients with acute myocardial infarction: a pilot study Articolo in rivista Vai
2011 Heat Shock Protein-60 and Risk for Cardiovascular Disease. Articolo in rivista Vai
2011 Effects of hypolipidemic and hypoglycemic agents on atherogenic small, dense LDL in Type 2 diabetes Articolo in rivista Vai
2011 Changes in immunohistochemical levels and subcellular localization after therapy and correlation and colocalization with CD68 suggest a pathogenetic role of Hsp60 in ulcerative colitis. Articolo in rivista Vai
2011 High resolution computed tomography quantitation of emphysema is correlated with selected lung function values in stable COPD. Articolo in rivista Vai
2011 Cilostazol and atherogenic dyslipidemia: a clinically relevant effect Articolo in rivista Vai
2011 Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction Articolo in rivista Vai
2011 Evaluation of the possible contribution of antioxidants administration in metabolic syndrome. Articolo in rivista Vai
2011 "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary. Articolo in rivista Vai
2011 There is more to predicting vascular disease than just established risk factors. Articolo in rivista Vai
2011 Marshall's vein persistence: A rare and occasional finding during pacemaker implantation Articolo in rivista Vai
2011 Therapeutic modulation of lipoprotein-associated phospholipase A2 (Lp-PLA2). Articolo in rivista Vai
2011 New lipid modulating drugs: the role of microsomal transport protein inhibitors. Articolo in rivista Vai
2011 "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Articolo in rivista Vai
2011 Ezetimibe, cardiovascular risk and atherogenic dyslipidaemia. Articolo in rivista Vai
2011 Recent insights into the relationship between inflammatory liver diseases and atherosclerosis. Articolo in rivista Vai
2010 The role of small, dense LDL in cardiovascular risk: the contribution of the universities of Palermo and Zurich Capitolo o Saggio Vai
2010 An update on the role of markers of inflammation in atherosclerosis Articolo in rivista Vai
2010 Should we measure routinely oxidized and small dense low-density lipoproteins in subjects with type 2 diabetes Articolo in rivista Vai
2010 Ezetimibe alone or in combination with simvastatin increases small, dense low-density lipoproteins in healthy men: a randomized trial Articolo in rivista Vai
2010 Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. Abstract in rivista Vai
2010 Lomitapide, a microsomal triglyceride transfer protein inhibitor for the treatment of hypercholesterolemia. Articolo in rivista Vai
2010 Effects of rosiglitazone on fasting and postprandial low- and high-density lipoproteins size and subclasses in type-2 diabetes. Articolo in rivista Vai
2010 An update on the relationships between rheumatoid arthritis and atherosclerosis. Articolo in rivista Vai
2010 Ezetimibe with or without simvastatin increases small dense low-density lipoproteins in healthy men – a randomized trial Abstract in rivista Vai
2010 Fasting and postprandial effects of rosiglitazone on low- and high-density lipoproteins size and subclasses in type-2 diabetes. eedings Vai
2010 Ethnic differences in serum lipoproteins and their determinants in South African women. Articolo in rivista Vai
2010 Interleukin-18 levels are associated with low-density lipoproteins size. Articolo in rivista Vai
2010 Increased plasma resistin concentrations are associated with atherogenic small, dense low-density lipoproteins in patients with type-2 diabetes eedings Vai
2010 Is diabetes the cost to pay for a greater cardiovascular prevention? Articolo in rivista Vai
2010 Effects of dark chocolate on cardiovascular risk Articolo in rivista Vai
2010 Associations of fructose and glucose consumption with LDL particle size in the diet of healthy swiss men Abstract in rivista Vai
2009 Recent insights on atherogenic dyslipidemia and cardiovascular risk. Articolo in rivista Vai
2009 Atherogenic dyslipidemia and oxidative stress: a new look Articolo in rivista Vai
2009 Senescenza ed allergia respiratoria. Capitolo o Saggio Vai
2009 The predictive role of atherogenic dyslipidemia in subjects with non-coronary atherosclerosis Articolo in rivista Vai
2009 Effetti della dialisi sul rischio cardiovascolare nei pazienti uremici: aumento delle particelle remnants Capitolo o Saggio Vai
2009 Therapy with non-invasive ventilation in patients with obstructive sleep apnoea: effects on atherogenic lipoprotein phenotype. Articolo in rivista Vai
2009 Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24 months follow-up study. eedings Vai
2009 Atherogenic forms of dyslipidemia in women with polycystic ovary syndrome Articolo in rivista Vai
2009 The predictive role of C-reactive protein in subjects with hypertension and subclinical atherosclerosis Articolo in rivista Vai
2009 Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy. Articolo in rivista Vai
2009 Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension. Articolo in rivista Vai
2009 Ethnic differences in serum lipids and the association with insulin sensitivity, body composition and lifestyle factors in south african women. Abstract in rivista Vai
2009 Utilità della citologia nasale. eedings Vai
2009 Milder forms of atherogenic dyslipidemia in ovulatory vs. anovulatory polycystic ovary syndrome phenotype. eedings Vai
2009 The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance? Articolo in rivista Vai
2009 Low circulating levels of HDL-cholesterol in women with PCOS and no other lipid abnormalities are associated to increased carotid intima media thickness and finding of atherogenic plaques. eedings Vai
2009 LDL size and subclasses in patients with abdominal aortic aneurysm Articolo in rivista Vai
2009 Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis. Articolo in rivista Vai
2009 Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension eedings Vai
2009 Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome Articolo in rivista Vai
2009 The effects of ezetimibe on LDL-cholesterol: quantitative or qualitative changes ? Articolo in rivista Vai
2009 When periods stop: cardiovascular consequences of PCOS. Capitolo o Saggio Vai
2009 Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP4-inhibitors. Articolo in rivista Vai
2009 Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis. eedings Vai
2009 Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions. eedings Vai
2009 Small dense low-density lipoproteins and peripheral arterial disease Altro Vai
2009 Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and the metabolic syndrome. eedings Vai
2009 Quantitative and qualitative effects of rosuvastatin on LDL-cholesterol: what is the clinical significance ? Articolo in rivista Vai
2009 Prediction of cerebrovascular and cardiovascular events in patients with subclinical carotid atherosclerosis: the role of C-reactive protein. eedings Vai
2009 Lipid pattern alterations in PCOS. eedings Vai
2009 Clinical importance of eosinophil count in nasal fluid in patients with allergic and non-allergic rhinitis Articolo in rivista Vai
2009 Elevated levels of non-HDL-cholesterol are relatively uncommon in women with PCOS and generally reflect LDL-cholesterol levels. eedings Vai
2009 Long-term consequences of polycystic ovary syndrome on cardiovascular risk Articolo in rivista Vai
2009 Should we routinely measure low-density and high-density lipoprotein subclasses? Articolo in rivista Vai
2009 Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype Articolo in rivista Vai
2008 Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions Articolo in rivista Vai
2008 Small, dense low-density lipoproteins are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome. eedings Vai
2008 Fever of unknown origin in a mediterranean survey from a division of internal medicine: report of 91 cases during a twelve-year-period (1991-2002) Articolo in rivista Vai
2008 Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial LDL-size and subclasses in patients with type-2 diabetes. Abstract in rivista Vai
2008 How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome? Articolo in rivista Vai
2008 Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease Articolo in rivista Vai
2008 Post-prandial alterations in LDL size and subclasses in patients with growth hormone deficiency. Articolo in rivista Vai
2008 Inflammation and atherosclerosis: recent insights and future perspectives. Articolo in rivista Vai
2008 Do we need better lipid tools for cardiovascular risk assessment ? Articolo in rivista Vai
2008 The atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. eedings Vai
2008 Non-classic forms of atherogenic dyslipidemia in women with polycystic ovary syndrome. Abstract in rivista Vai
2008 The atherogenic lipoprotein phenotype as predictor of cardiovascular events in patients with non-coronary forms of atherosclerosis. Abstract in rivista Vai
2008 PREDICTION OF CEREBROVASCULAR AND CARDIOVASCULAR EVENTS IN PATIENTS WITH SUBLINICAL CAROTID ATHEROSCLEROSIS: THE ROLE OF C-REACTIVE PROTEIN Articolo in rivista Vai
2008 Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review. Articolo in rivista Vai
2008 Recent insights on dark chocolate consumption and cardiovascular risk. Articolo in rivista Vai
2008 Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol Articolo in rivista Vai
2008 Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study Articolo in rivista Vai
2008 A practical method to determine the “atherogenic lipoprotein phenotype” Articolo in rivista Vai
2008 The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance? Articolo in rivista Vai
2008 Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes Articolo in rivista Vai
2008 Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. Articolo in rivista Vai
2007 The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibrates Articolo in rivista Vai
2007 L’eta’ e gli elevati livelli di proteina C-reattiva e fibrinogeno sono forti predittori di eventi clinici in una popolazione di donne con aterosclerosi carotidea. Articolo in rivista Vai
2007 Interleukin 6 plasma levels predict with high sensitivity and specificity coronary stenosis detected by coronary angiography Articolo in rivista Vai
2007 Who needs to care about small, dense low density lipoproteins? Articolo in rivista Vai
2007 Androgen excess and cardiovascular risk. Articolo in rivista Vai
2007 Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome Articolo in rivista Vai
2007 Update on the role of the atherogenic lipoprotein phenotype in cardiovascular prevention. Articolo in rivista Vai
2007 Small, dense low-density-lipoproteins and the metabolic syndrome. Articolo in rivista Vai
2007 INTERLEUKIN 6 PLASMA LEVELS PREDICT WITH HIGH SENSITIVITY AND SPECIFICITY CORONARY STENOSIS DETECTED BY CORONARY ANGIOGRAPHY eedings Vai
2007 L’eta’ e gli elevati livelli di proteina C-reattiva e fibrinogeno sono forti predittori di eventi clinici in una popolazione di donne con aterosclerosi carotidea. eedings Vai
2007 Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy Articolo in rivista Vai
2007 Low-density-lipoprotein heterogeneity and the metabolic syndrome. Capitolo o Saggio Vai
2007 The clinical relevance of LDL size and subclasses modulation in patients with type-2 diabetes Articolo in rivista Vai
2007 La presenza di disfunzione endoteliale e di aterosclerosi carotidea sono forti predittori di eventi clinici in pazienti asintomatici. Articolo in rivista Vai
2007 An update on the role of the quality of LDL in cardiovascular risk: the contribution of the Universities of Palermo and Zurich. Articolo in rivista Vai
2007 Therapeutic patient education in oncology: pedagogical notions for women's health and prevention. Articolo in rivista Vai
2007 ASSOCIATION OF ELEVATED FIBRINOGEN AND C-REACTIVE PROTEIN LEVELS WITH CAROTID LESIONS IN PATIENTS WITH EARLY ONSET OF HYPERTENSION OR TYPE-II DIABETES eedings Vai
2007 Effects of statins, fibrates, rosuvastatin and ezetimibe beyond cholesterol: the modulation of LDL size and subclasses in high-risk patients. Articolo in rivista Vai
2006 Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Articolo in rivista Vai
2006 ASSOCIATION OF ELEVATED FIBRINOGEN AND C-REACTIVE PROTEIN LEVELS WITH CAROTID LESIONS IN PATIENTS WITH EARLY ONSET OF HYPERTENSION OR TYPE II DIABETES. eedings Vai
2006 Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease Articolo in rivista Vai
2006 Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity. Articolo in rivista Vai
2006 La presenza di disfunzione endoteliale e di aterosclerosi carotidea sono forti predittori di eventi clinici in pazienti asintomatici. Abstract in rivista Vai
2006 Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patiens with early onset of hypertension or type-2 diabetes Abstract in rivista Vai
2006 The clinical significance of small, dense low-density lipoproteins Capitolo o Saggio Vai
2006 The significance of low-density lipoproteins size in vascular diseases Articolo in rivista Vai
2006 Effects of statins on low-density-lipoproteins size: a new role in cardiovascular prevention ? Articolo in rivista Vai
2006 Low-density lipoprotein size and cardiovascular risk assessment. Articolo in rivista Vai
2006 Should we measure routinely the LDL peak particle size? Articolo in rivista Vai
2006 Statins, fracture risk, and bone remodeling: What is true? Articolo in rivista Vai
2006 The clinical relevance of low-density-lipoproteins size modulation by statins. Articolo in rivista Vai
2006 The role of small, dense low-density lipoproteins in non-coronary forms of atherosclerosis. Articolo in rivista Vai
2006 Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. Articolo in rivista Vai
2006 ASSOCIATION OF ELEVATED FIBRINOGEN AND C-REACTIVE PROTEIN LEVELS WITH CAROTID LESIONS IN PATIENTS WITH NEWLY DIAGNOSED HYPERTENSION OR TYPE-II DIABETES Articolo in rivista Vai
2006 L’uso di stent con sirolimus e’ significativamente associate alla riduzione della mortalita’ totale e della morbidita’ cardiovascolare sia a 6 mesi che a 12 mesi post-PTCA. Abstract in rivista Vai
2006 Low-density-lipoproteins size and cardiovascular prevention Articolo in rivista Vai
2006 LA PRESENZA DI ELEVATI LIVELLI DI FIBRINOGENO E PROTEINA C-REATTIVA SONO SIGNIFICATIVAMENTE ASSOCIATI ALLA PRESENZA DI ATEROSCLEROSI CAROTIDEA NEI PAZIENTI IPERTESI O DIABETICI. eedings Vai
2006 Use of stents with sirolimus is significantly associated with a reduction in mortality and cardiovascular morbidity at 6- and 12-months post-PTCA Abstract in rivista Vai
2006 ELEVATED C-REACTIVE PROTEIN LEVELS ARE A STRONG PREDICTOR OF CLINICAL EVENTS IN HYPERTENSIVE PATIENTS WITH EARLY STAGE OF ATHEROSCLEROSIS eedings Vai
2006 Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with early onset of hyprtension or type-II diabetes Abstract in rivista Vai
2006 ELEVATED C-REATIVE PROTEIN LEVELS ARE STRONG PREDICTOR OF CLINICAL EVENTS IN HYPERTENSIVE PATIENTS WITH EARLY STAGES OF ATHEROSCLEROSIS eedings Vai
2006 Elevati livelli di proteina C-reattiva sono predittivi di eventi clinici nei pazienti ipertesi con lesioni carotidee asintomatiche Abstract in rivista Vai
2005 Diabetes, family hystory and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study Articolo in rivista Vai
2005 A case of bowel schistosomiasis that did not adhere to the endoscopic findings. Articolo in rivista Vai
2005 Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention? Articolo in rivista Vai
2005 Cystatin C levels are decreased in acute myocardial infarction: Effect of cystatin C G73A gene polymorphism on plasma levels Articolo in rivista Vai
2005 Family hystory, diabetes and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study Articolo in rivista Vai
2005 Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A. Articolo in rivista Vai
2005 PROGNOSTIC IMPACT OF HYPERTENSION AND CAROTID LESIONS IN A FIVE YEARS FOLLOW UP eedings Vai
2005 Relazione tra il size delle LDL e l’estensione della malattia vasale coronarica in 72 pazienti maschi sottoposti a coronarografia diagnostica Abstract in rivista Vai
2005 Effects of combined estrogen+progestin hormone therapy on hepatic lipase and lipoprotein lipase levels. Atherosclerosis. 2005. 6(suppl.1) eedings Vai
2005 PROGNOSTIC IMPACT OF HYPERTENSION AND CAROTIID LESIONS N A FIVE YEARS FOLLOW UP eedings Vai
2005 Prognostic impact of hypertension and carotid lesions in a five years follow-up Abstract in rivista Vai
2005 Relationship between endothelial dysfunction, intima media thickness, and other cardiovascular risk factors in asymptomatic subjects Abstract in rivista Vai
2005 Drug eluting stents's use in patients with anatomical or clinical patterns favouring restenosis: a 6-months follow-up study eedings Vai
2005 Drug eluting stents's use in patients with anatomical or clinical patterns favouring restenosis: a 6-months follow-up study. Atherosclerosis. 2005. 6(suppl.1) eedings Vai
2005 FIBRINOGEN AS PREDICTOR OF MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION: A 42-MONTHS FOLLOW-UP STUDY Articolo in rivista Vai
2005 Effects of combined estrogen+progestin hormone therapy on hepatic lipase and lipoprotein lipase levels Abstract in rivista Vai
2004 Infection and inflammation influence the outcome of patients with asymptomatic carotid lesions Abstract in rivista Vai
2004 Rickttsial disease: classical and modern aspects Articolo in rivista Vai
2004 Effects “beyond-cholesterol” by statins: a 3-months therapy with simvastatin reduces the atherogenic lipoproteins in patients with premature coronary artery disease and in absence of the traditional cardiovascular risk factors. Articolo in rivista Vai
2004 Statins and osteoporosis: myth or reality? Articolo in rivista Vai
2004 Effects on lipoprotein subclasses of combined expression of human hepatic lipase and human apoB in transgenic rabbits Articolo in rivista Vai
2004 Transient chylomicronemic syndrome: description of three cases Abstract in rivista Vai
2004 Plasma clearance of human low-density lipoprotein in human apolipoprotein B trangenic mice is related to particle diameter Articolo in rivista Vai
2004 LDL size: does it matter ? Articolo in rivista Vai
2004 Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. Articolo in rivista Vai
2004 Stent nudi e stent medicati con sirolimus nel registro RESTEM Abstract in rivista Vai
2004 Use of the drug eluting stents with rapamicin in patients with anatomical or clinical patterns favouring restenosis: results of a 6-months follow-up on the first 100 patients. Abstract in rivista Vai
2004 L’ehrlichiosi: una patologia emergente Articolo in rivista Vai
2004 Diabetes, family history and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study Abstract in rivista Vai
2004 I LIVELLI DI CISTATINA C SONO RIDOTTI NELL’INFARTO MIOCARDIO ACUTO. EFFETTO DEL POLIMORFISMO G73A SUI LIVELLI PLASMATICI. eedings Vai
2004 USE OF THE DRUG ELUTING STENTS WITH RAPAMICIN IN PATIENTS WITH ANATOMICAL OR CLINICAL PATTERNS FAVOURING RESTENOSIS: RESULTS OF A 6-MONTHS FOLLOW-UP ON THE FIRST 100 PATIENS. eedings Vai
2004 The malnutrition in the elderly: a clinical approach. Articolo in rivista Vai
2004 Risultati del follow-up di 6 mesi in 100 pazienti con stent medicato con rapamicina rispetto ad altri 100 con stent tradizionale Abstract in rivista Vai
2004 PEAK PARTICLE SIZE AND THE EXTENSION OF CORONARY ATHEROSCLEROSIS IN 71 PATIENTS THAT UNDERWENT AN ANGIOGRAPHIC EXAM eedings Vai
2004 Diabetes, family history and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study. Intenational Angiology. 2004. 23(suppl.1) eedings Vai
2004 Diabetes, family history and extension of coronary atherosclerosis are strong predictors of adverse events post-PTCA: a 1 year follow-up study Abstract in rivista Vai
2004 Dati del follow-up di 6 mesi sui primi 100 pazienti con stent medicati con rapamicina, con situazioni anatomiche e cliniche favorenti la restenosi Abstract in rivista Vai
2004 Il diabete, la familiarita’ per malattie cardiovascolari e l’estensione della malattia vasale quali predittori degli eventi clinici ad 1 anno di follow-up post-PTCA Abstract in rivista Vai
2004 Infection and inflammation influence the outcome of patients with asymptomatic carotid lesions. Int Angiol. 2004. 23(suppl.1) eedings Vai
2004 EFFETTI “BEYOND CHOLESTEROL” DELLE STATINE Articolo in rivista Vai
2004 LDL peak particle size and the extension of coronary atherosclerosis in 72 patients that underwent an angiographic exam eedings Vai
2004 Uso degli stent medicati con rapamicina in pazienti con situazioni anatomiche o cliniche che favoriscono la restenosi: risultati del follow-up di 6 mesi su primi 100 pazienti Abstract in rivista Vai
2004 I livelli di cistatina C sono ridotti nell’infarto miocardico acuto. Effetto del polimorfismo G273A sui livelli plasmatici Abstract in rivista Vai
2004 Use of the drug eluting stents with rapamicin in patients with anatomical or clinical patterns favouring restenosis: results of a 6-months follow-up on the first 100 patients Abstract in rivista Vai
2004 Hepatic lipase and lipoprotein lipase are affected by combined estrogen+progestin hormone therapy Abstract in rivista Vai
2004 Use of the drug eluting stents with rapamicin in patients with anatomical or clinical patterns favouring restenosis: results of a 6-months follow-up on the first 100 patients. Intenational Angiology. 2004. 23(suppl.1) eedings Vai
2004 INFECTION AND INFLAMMATION INFLUENCE THE OUTCOME OF PATIENTS WITH ASYMPTOMATIC CAROTID LESIONS eedings Vai
2004 La sindrome orticaria-angioedema: una patologia internistica ad espressione cutanea. [Urticaria and angioedema. A general affection rather than a specific cutaneous disease]. Articolo in rivista Vai
2004 Le LDL generate in fase post-prandiale dopo carico grasso presentano maggiore densita’, minore size e maggiore affinita’ per il recettore Abstract in rivista Vai
2003 Validita’ clinica dei marker ossei. Abstract in rivista Vai
2003 Low-density-lipoprotein peak particle size in a Mediterranean population. Articolo in rivista Vai
2003 La vitamina D in pazienti adulti affetti da talassemia major Abstract in rivista Vai
2003 La somministrazione di amfotericina B per via endoarteriosa rappresenta una valida e sicura terapia della mucormicosi eedings Vai
2003 La somministrazione di amphotericina B per via endoarteriosa rappresenta una valida e sicura terapia della mucormicosi Abstract in rivista Vai
2003 Differential apolipoprotein(a) isoform expression in heterozygosity is an independent contributor to lipoprotein(a) levels variability Articolo in rivista Vai
2003 Fattori di rischio cardiovascolari, sindrome plurimetabolica e disfunzione endoteliale Abstract in rivista Vai
2003 Saturated and unsaturated free fatty acids (FFA) modulate differently HDL uptake in hepatoma HEPG2 cells Abstract in rivista Vai
2003 Associazione di più fattori di rischio e d’elevati livelli di fibrinogeno e PCR: ruolo predittivo di complicanze vascolari in una popolazione di soggetti con NIDDM Abstract in rivista Vai
2003 Comparison of the effects of metformin and rosiglitazone in anovulatory women with polycystic ovary syndrome (PCOS) Abstract in rivista Vai
2003 Lipoprotein remnants accumulation in end-stage renal disease: evidence of an active role of heparin administration during hemodialysis Abstract in rivista Vai
2003 Su un caso sospetto di schistosomiasi Abstract in rivista Vai
2003 LDL size, density and receptor affinity variation during an oral load in mild hyper-triglyceridemic and normal subjects Abstract in rivista Vai
2003 Accumulation of remnant-like particles in normolipidemic men with premature coronary artery disease Abstract in rivista Vai
2003 Predective role of asymptomatic carotid lesions for cardiovascular and cerebrovascular, fatal and non fatal, events in a 5-years follow-up study Abstract in rivista Vai
2003 Risultati immediati e a lungo termine della valvuloplastica mitralica percutanea: un’esperienza di dieci anni. Abstract in rivista Vai
2003 L’amphotericina B liposomiale somministrata per via endoarteriosa rappresenta una sicura e valida terapia della mucormicosi Abstract in rivista Vai
2003 L’ipertensione è una variabile associata alla presenza di lesioni carotidee, nonché predittiva di eventi avversi durante il follow-up di 5 anni Abstract in rivista Vai
2003 Coronarografia diagnostica e conseguenti scelte terapeutiche dopo l’avvento degli stent alla rapamicina: approccio attuale ed evoluzione degli ultimi dieci anni. Abstract in rivista Vai
2003 Studio sulla prevalenza di fratture vertebrali e loro identificazione con esame morfometrico e morfometria digitale Abstract in rivista Vai
2003 Comparison between different mathematical methods to calcolate insulin resistance in women with polycystic ovary syndrome (PCOS) Abstract in rivista Vai
2003 Clinical predictors of adverse events in a 1 year follow-up study post-PCI Abstract in rivista Vai
2003 Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene. Articolo in rivista Vai
2002 Low prevalence of the atherogenic small, dense LDL in a mediterranean population. Nutrition, Metabolism and Cardiovascular Diseases Abstract in rivista Vai
2002 CD14 C(-260)>T gene polymorphism is not a risk factor for myocardial infarction eedings Vai
2002 Il fibrinogeno come predittore di mortalita’ in un follow-up di 42 mesi post-infarto miocardico acuto Abstract in rivista Vai
2002 Simvastatin reduces the levels of ApoE-containing triglyceride-rich lipoproteins in men with premature coronary artery disease Abstract in rivista Vai
2002 Changes in levels of triglyceride-rich lipoprotein subfractions during dialysis in uremic patients Abstract in rivista Vai
2002 Distribution of risk factors, plasma lipids, lipoproteins and dyslipidemias in a small Mediterranean island: the Ustica Project Articolo in rivista Vai
2002 Bassa prevalenza delle LDL aterogene piccole e dense in una popolazione mediterranea Abstract in rivista Vai
2002 Complicazioni intra-ospedaliere in pazienti ipertesi con infarto miocardico acuto: uno studio retrospettivo di tipo caso-controllo Abstract in rivista Vai
2002 Correlazione fra deficit di vit.D monoidrossilata e danno epatico in soggetti talassemici adulti Abstract in rivista Vai
2002 Descrizione di una famiglia siciliana con iper-alfa-lipoproteinemia con deficit di CETP Abstract in rivista Vai
2002 Accumulo di particelle aterogene remnants dopo la dialisi in pazienti uremici Abstract in rivista Vai
2002 Nutritional characteristics of a rural Southern Italy population: the Ventimiglia di Sicilia Project Articolo in rivista Vai
2002 Lesioni carotidee asintomatiche quale marker di futuri eventi cardiovascolari e cerebrovascolari nel follow-up a lungo termine: correlazione con gli indici di flogosi e le infezioni da cytomegalovirus, chlamydia pneumoniae, helicobacter pylori Abstract in rivista Vai
2002 Studio epidemiologico “Ustica”: bassa prevalenza delle LDL aterogene in una popolazione mediterranea Abstract in rivista Vai
2002 Il polimorfismo genico del CD14 C(-260)>T non e’ un fattore di rischio per infarto miocardico acuto Abstract in rivista Vai
2002 Valutazione dell’outcome a distanza post-PTCA: risultati del follow-up ad un anno Abstract in rivista Vai
2002 Asymptomatic carotid lesion as marker of future cerebrovascular and cardiovascular events in the follow-up: correlation with markers of inflammation and the infections from cytomegalovirus, chlamydia pneumoniae, helicobacter pylori Abstract in rivista Vai
2002 La simvastatina riduce le lipoproteine aterogene in pazienti con coronaropatia prematura: effetti delle statine “beyond-cholesterol” Abstract in rivista Vai
2002 Levels of b-sitosterol in a sicilian sample of hyper-cholesterolemic patients Abstract in rivista Vai
2002 Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction Articolo in rivista Vai
2002 Il polimorfismo genico CD14 C(-260)>T non e’ un fattore di rischio per infarto miocardico acuto Abstract in rivista Vai
2002 La simvastatina riduce le lipoproteine aterogene in pazienti con coronaropatia prematura: effetti delle statine “beyond-cholesterol” Abstract in rivista Vai
2002 Clinical predictors of adverse events in a 1 year follow-up study post-PTCA. Abstract in rivista Vai
2002 Bassa prevalenza delle LDL aterogene piccole e dense in una popolazione mediterranea Abstract in rivista Vai
2002 Effects “beyond-cholesterol” of statins: simvastatin reduces the levels of atherogenic lipoproteins in patients with premature coronary artery disease Abstract in rivista Vai
2002 Fibrinogen as predictor of mortality in a 42-months follow-up after acute myocardial infarction Abstract in rivista Vai
2002 Trombosi portale mesenterica idiopatica in paziente con doppia mutazione eterozigote del gene C677T e del gene A1298C della MTHFR Abstract in rivista Vai
2002 CD14 C(-260)>T gene polymorphism is not a risk factor for myocardial infarction eedings Vai
2002 Coronarografia diagnostica: evoluzione temporale in relazione ai progressi della PTCA Abstract in rivista Vai
2002 Su un caso di ascesso epatico in paziente sottoposta a TACE per HCC Abstract in rivista Vai
2002 Effects of dialysis on the cardiovascular risk of uremic patients: increase in levels of remnant particles Abstract in rivista Vai
2002 Effetti “beyond-cholesterol” delle statine: la terapia con simvastatina riduce le lipoproteine aterogene in pazienti con coronaropatia prematura Abstract in rivista Vai
2002 Livelli plasmatici di fibrinogeno in soggetti con infarto miocardico acuto: relazione con gli eventi nel follow-up a 42 mesi Abstract in rivista Vai
2002 Febbre di origine sconosciuta (FUO): due casisitiche di una medesima divisione di medicina interna a confronto Abstract in rivista Vai
2002 Livelli di b-sitosterolo in una popolazione siciliana di pazienti ipercolesterolemici Abstract in rivista Vai
2002 Variations in plasma lipids and in the LDL peak particle size after acute myocardial infarction Abstract in rivista Vai
2002 Description of a sicilian family with hyper-alpha-lipoproteinemia with deficit of CETP activity Abstract in rivista Vai
2001 Le variazioni dei valori dell’assetto lipidico durante la risposta di fase acuta post-infarto miocardico acuto sono accompagnate da modifiche nel size delle LDL Abstract in rivista Vai
2001 ApoE polymorphism in a small Mediterranean island: Relationships with plasma lipids, lipoproteins and LDL particle size Articolo in rivista Vai
2001 Correlazione in 309 pazienti coronaropatici tra i livelli di HDL-colesterolo e l’estensione della coronaropatia Abstract in rivista Vai
2001 Andamento nel tempo dell’approccio alla coronarografia diagnostica in relazione ai progressi della PTCA Abstract in rivista Vai
2001 Dati di mortalita’ e morbilita’ del follow-up condotto su 123 pazienti sottoposti ad angioplastica coronarica Abstract in rivista Vai
2001 Livelli ridotti di cistatina C nell’infarto miocardico acuto vs. angina instabile, aneurisma aortico e controlli normali Abstract in rivista Vai
2001 Variazioni delle sottofrazioni delle lipoproteine ricche in trigliceridi durante la dialisi in soggetti uremici Abstract in rivista Vai
2001 Prevalenza di fattori di rischio e variazione temporale dei parametri lipidici in una serie consecutiva di 350 infarti acuti del miocardio registrati in una unita’ intensiva di Palermo. Abstract in rivista Vai
2001 Chilomicronemia transitoria causa di diabete di tipo I in assenza di markers umorali di autoimmunità in una bambina di nove anni Abstract in rivista Vai
2000 Treatment of primary hypercholesterolemia: comparison of the effectiveness of different statins Abstract in rivista Vai
2000 Descrizione di un modello minimo per lo studio della cinetica dei chilomicroni dopo pasto grasso Abstract in rivista Vai
2000 Accumulo di VLDL/IDL contenenti ApoE in maschi normolipemici con cardiopatia ischemica precoce Abstract in rivista Vai
2000 Accumulation of ApoE-containing triglyceride-rich lipoproteins in normolipidemic men with premature coronary artery disease eedings Vai
1999 Overexpression of human hepatic lipase and ApoE in transgenic rabbits attenuates response to dietary cholesterol and alters lipoprotein subclass distributions. Articolo in rivista Vai